LEO is a purpose-designed solution built with Google Cloud for smarter, faster, and more efficient sustainability disclosure, ...

DXC Technology (DXC) has appointed Anders Lange as Chief Procurement Officer, effective immediately. Lange will report to DXC’s Chief ...

LEO Pharma is developing a wearable device based on miniature sensors and plans to assess its clinical potential in dermatology drug development. The pharmaceutical company’s Boston-based R&D ...

The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Commission (EC) have approved a change to the terms of the marketing authorisation for LEO Pharma’s Adtralza ...

Royalty Pharma (RPRX) announced the appointment of Vlad Coric to the company’s board of directors, effective immediately. Vlad Coric is the chairman and CEO of Biohaven (BHVN). Published first ...

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...

Roni Kamhi, CEO BI Sky Global and COO of Innocan Pharma commented: "We are very pleased with our outstanding results and especially our strong revenue growth. At BI Sky Global we are clearly ...

Following the recently granted patent in India for a prolonged-release pharmaceutical formulation using liposomes to encapsulate CBD, Innocan is actively advancing its efforts to strengthen ...

Preclinical research is crucial for the development of any novel drug. It demands significant resources that are often expensive and inaccessible to biotechnology and pharmaceutical companies of ...

Strides Pharma Science Ltd, Aarti Pharma Ltd, Marksans Pharma Ltd, Laurus Labs and IPCA Labs led losers on the BSE Healthcare index, as the party got over in the pharma pack early after the US ...

“Our first reaction is one of relief. That said, we remain very vigilant and concerned about the future,” said David Gering from Pharma.be. He added that the American market represents a signi ...